Skip to main content

and
  1. Article

    Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective

    Coronavirus disease of 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly the world over. The disease was declared “pandemic” by the World He...

    Azita Hajhossein Talasaz, Hessam Kakavand in Cardiovascular Drugs and Therapy (2021)

  2. Article

    Open Access

    Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fraction

    – Coronary microvascular dysfunction (CMD) is common in patients with heart failure with preserved ejection fraction (HFpEF) and obesity. Stress cardiovascular magnetic resonance (CMR) has been proposed as a n...

    Roshanak Markley, Marco Giuseppe Del Buono in The International Journal of Cardiovascula… (2023)

  3. No Access

    Article

    ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights

    This review describes the discovery and development of ACE inhibitors as antihypertensive agents, compares their efficacy, tolerability, and safety to ARBs, and highlights the contemporary issues surrounding A...

    Stacey Cutrell, Ibrahim S. Alhomoud, Anurag Mehta in Current Hypertension Reports (2023)